Categories
- Aesthetic Medicine
- Aesthetic Surgery
- Ai
- ALS Treatment
- Anatomy
- Artificial General Intelligence
- Artificial Intelligence
- Artificial Super Intelligence
- Batten Disease Treatment
- BioEngineering
- BioInformatics
- Biology
- Biotechnology
- Bitcoin
- Brain Injury Treatment
- Cardiac Nursing
- Cardiac Regeneration
- Cardiac Remodeling
- Cardiac Rhythm Abnormalities
- Cardiac Surgery
- Cardiology
- Cardiomyopathies
- Cardiovascular Pharmacology
- Cell Medicine
- Cell Therapy
- Cerebral Palsy
- Cerebral Palsy Treatment
- Cheap Pharmacy
- Chemistry
- Clinical Cardiology
- Coronary Heart Diseases
- Cryptocurrency
- DNA
- Drug Dependency
- Drug Side Effects
- Drugs
- Eczema
- Elon Musk
- Embryology
- Erectile Dysfunction
- FDA Stem Cell Trials
- Femtomedicine
- Future Medicine
- Gene Medicine
- Gene Therapy
- Gene Therapy Trials
- Genetic Engineering
- Genetic Therapy
- Genetics
- Germ Line Engineering
- Heart Diseases
- HGH
- Hgh Injections
- Hormone Replacement Therapy
- Human Genetics
- Human Growth Hormone
- Human Immortality
- Hyperbaric Medicine
- Hypertension
- Hypothalamus
- Impotency
- Internet Pharmacy
- Interventional Cardiology
- IVF Treatment
- Lyme Disease
- Male Sexual Dysfunction
- Mars Colony
- Medical Business
- Medical School
- Medical Technology
- Medicine
- Mental Health
- Mesenchymal Stem Cells
- Micropenia
- Molecular Cardiology
- MS Treatment
- Muscular Dystrophy Treatment
- Myocardial Infarction
- Nanotechnology
- Online Pharmacy
- Oral Health
- Parkinson's Treatment
- Pediatric Cardiology
- Penis Enlargement
- Pet Stem Cell Therapy
- Pharmacy
- Picomedicine
- Premature Ejaculation
- Prescriptions
- Retinitis Pigmentosa
- Sermorelin
- Singularity
- Sleep
- Spacex
- Spinal Cord Injury Treatment
- Stem Cell Clinical Trials
- Stem Cell Experiments
- Stem Cell Human Trials
- Stem Cell Injections
- Stem Cell Research
- Stem Cell Transplant
- Stem Cell Treatments
- Testosterone
- Ulcerative Colitis
- Uncategorized
- Vascular Biology
- Ventricular Remodeling
- Wholesale Pharmacy
Archives
Monthly Archives: March 2012
Bioheart and Ageless Partner to Advance Stem Cell Field With Laboratory Training Programs
Posted: Published on March 15th, 2012
SUNRISE, Fla., March 15, 2012 (GLOBE NEWSWIRE) -- Bioheart, Inc. (BHRT.OB) announced today that it has successfully conducted a laboratory training course in partnership with the Ageless Regenerative Institute, an organization dedicated to the standardization of cell regenerative medicine. The attendees participated in hands on, in depth training in laboratory practices in stem cell science. "We had students from all over the world attend this first course including physicians, laboratory technicians and students," said Mike Tomas, Bioheart's President and CEO. "Bioheart is pleased to be able to share our 13 years of experience in stem cell research and help expand this growing life science field." The course included cell culture techniques and quality control testing such as flow cytometry and gram stain. In addition, participants learned how to work in a cleanroom operating according to FDA cGMP standards, regulations used in the manufacture of pharmaceuticals, food and medical devices. Aseptic techniques were also taught as well as cleanroom gowning, environmental monitoring and maintenance. Future courses are open to physicians, laboratory technicians and students. After graduating the course, attendees are prepared to pursue research and careers in the field of stem cells and regenerative medicine. For more information about the course, … Continue reading
Comments Off on Bioheart and Ageless Partner to Advance Stem Cell Field With Laboratory Training Programs
Suspended doctor disputes DOH claims
Posted: Published on March 15th, 2012
LEE COUNTY, FL - The attorney for a Bonita Springs doctor whose license was suspended last week after a patient's death now says a different doctor was treating the patient and the patient had not received a stem cell treatment. Dr. Zannos Grekos is under investigation by the Lee County Sheriff's Office, however no criminal charges have been filed against him. Dr. Grekos' attorney issued a one page statement to our newsroom that says the patient died during a different procedure performed by a different doctor.[Click here to read the statement.] The attorney did not identify the doctor on the statement, but says the other doctor was performing liposuction on THE MAN, not stem cell treatment. The family of 77 year old Richard Poling of Indiana said he was being treated for pulmonary fibrosis. The Department of Health's Emergency Suspension Order stated Poling died from cardiac arrest while at Grekos' office. Dr Grekos' attorney states that the medical examiner's office has not provided a report linking the patient's death to stem cell treatment. We did reach out to the Department of Heath for comment, but have not heard back from them yet. We also reached out to Poling's sister who … Continue reading
Comments Off on Suspended doctor disputes DOH claims
Medtronic Receives Health Canada License for Deep Brain Stimulation Therapy in Refractory Epilepsy Patients
Posted: Published on March 15th, 2012
BRAMPTON, Ontario & MINNEAPOLIS--(BUSINESS WIRE)-- Medtronic, Inc. (NYSE: MDT - News) today announced that it has received from Health Canada a license for Medtronic Deep Brain Stimulation (DBS) Therapy for refractory epilepsy patients. Medtronic DBS therapy for refractory epilepsy delivers controlled electrical pulses to a location inside the brain which is involved in seizures. The Health Canada license was based on data collected in Medtronics clinical trial called SANTE (Stimulation of the Anterior Nucleus of the Thalamus in Epilepsy). The SANTE trial was a prospective, randomized, double-blind pivotal study to evaluate the use of DBS therapy for patients with medically refractory epilepsy with partial-onset seizures. The trial collected data from 110 patients who were implanted with a Medtronic DBS system at 17 centers in the United States. Medtronic DBS Therapy for refractory epilepsy is also approved in Europe. The therapy is not currently approved by the U.S. Food and Drug Administration for use in the United States for the treatment of refractory epilepsy. To date, more than 85,000 patients worldwide have received Medtronic DBS therapy. The therapy is currently licensed in Canada and approved in other regions including the European Union and the United States, for the treatment of the … Continue reading
Comments Off on Medtronic Receives Health Canada License for Deep Brain Stimulation Therapy in Refractory Epilepsy Patients
Many Stroke Victims Not Calling 911
Posted: Published on March 15th, 2012
Editor's Choice Academic Journal Main Category: Stroke Article Date: 15 Mar 2012 - 10:00 PDT email to a friend printer friendly opinions Current Article Ratings: This finding underlines the need for further education regarding the importance of early intervention and stroke symptoms. The study, which evaluated data gathered between 1997 and 2008, by the National Hospital Ambulatory Medical Care Survey (NHAMCS), was led by Dr. Hooman Kamel, a neurologist at NewYork-Presbyterian Hospital/Weill Cornell and assistant professor of neurology at Weill Cornell Medical Collage. Dr. Kamel, explained: Based on 1,605 cases, only 51% of adults in the U.S. diagnosed with stroke in emergency departments arrived via ambulance, according to results of the study. In addition, the researchers found that over the 11 year span there was no considerable change. According to Dr. Kamel individuals can recover if they receive early treatment. Co-authors of the study are Dr. Babak Navi, director of the Weill Cornell Stroke Center and assistant professor at Weill Cornell Medical College, and Dr. Jahan Fahimi, an emergency physician and assistant professor at the University of California, San Francisco. MLA The rest is here: Many Stroke Victims Not Calling 911 … Continue reading
Comments Off on Many Stroke Victims Not Calling 911
Interlex Developing New Brand Positioning Strategy for American Heart Association/American Stroke Association
Posted: Published on March 15th, 2012
SAN ANTONIO, March 15, 2012 /PRNewswire/ --The nation's leading advocacy organization for heart health and stroke prevention, treatment and support is working with Interlex to conduct branding, awareness and attitudinal researchto develop a new positioning strategy for the American Stroke Association Brand. "For the past few months we've been deep into the research phase, conducting both quantitative and qualitative studies across General, African American, Asian American, Hispanic, South Asian, and Native American segments," said Interlex President and CEO Rudy Ruiz. The goal, according to Ruiz, is to help the Association build a brand platform and communications strategy which is universally appealing and multicultural at the core. "This is a national initiative," said Ruiz. "The American Heart Association/American Stroke Association is very committed to improving the health of all Americans. And since minority segments are often disproportionately impacted by stroke, it is very important that they reach these audiences in meaningful, motivational ways." Stroke is the number one preventable cause of disability in America, but - according to Ruiz - research shows that a majority of people aren't aware of its dangers, how to prevent it and how to detect its warning signs to save precious time when it occurs. "There … Continue reading
Comments Off on Interlex Developing New Brand Positioning Strategy for American Heart Association/American Stroke Association
Joyce Stevens Celms begins the long road back
Posted: Published on March 15th, 2012
Once, she danced the night away and was crowned the 1967 Holbrook High prom queen. Today, Joyce Stevens Celms, 62, lies in a bed in the spinal cord injury unit of Bostons Spaulding Rehabilitation Hospital, without movement in her legs or feet, following an accident in her Holbrook home. At about 9:30 p.m. on Feb. 20, Celms caught the tip of her boot on the linoleum in her kitchen and fell onto the floor with such momentum that her neck hyper-extended and she suffered a spinal cord injury. Celms sister, Nancy Stevens, did not hear her faint cries for help. I was asleep upstairs and could not hear her barely audible cries for help, which she knew, Stevens said. More than 10 hours later, Stevens discovered her sister stretched out on the floor, her eyes closed. Stevens cried out her sisters name. Thank God, her right eye flew open and she tried to talk, Stevens said. She remarkably survived the night. Celms was rushed to South Shore Hospital for emergency treatment, where doctors assessed the extent of the damage to her spinal cord and transferred her to Brigham and Womens Hospital in Boston. Upon arriving at Brigham and Womens, Celms … Continue reading
Posted in Spinal Cord Injury Treatment
Comments Off on Joyce Stevens Celms begins the long road back
InVivo Therapeutics ends 2011 with $34.7M net loss
Posted: Published on March 15th, 2012
InVivo Therapeutics Holdings Corp. (OTCBB: NVIV), which develops technologies for treatment of spinal cord injuries, reported a net loss of $34.7 million, or $0.67 per diluted share, for the year ending Dec. 31, 2011. Cambridge-based InVivos loss is up significantly from $7.9 million, or $0.24 per diluted share, for 2010. The company said that the net loss for 2011 included a non-cash derivative loss of $26 million, reflecting an increase in the fair value of the derivative warrant liability, and a pro forma net loss of $8.6 million. Total operating expenses for 2011 were $8.7 million compared with $3.4 million for 2010, and research and development costs in 2011 were $4.1 million, up from $1.7 in 2010. General and administrative expense rose to $4.6 million from $1.7 million in 2010, which the company said was due to investments to expand infrastructure and added costs associated with public company practices. Still, Frank Reynolds, InVivos CEO, said 2011 was a landmark year for the company in a written statement, and that it performed under budget for the sixth consecutive year. We made significant progress advancing the commercialization of our first product for SCI and expanding our product pipeline to the rest of … Continue reading
Posted in Spinal Cord Injury Treatment
Comments Off on InVivo Therapeutics ends 2011 with $34.7M net loss
InVivo Therapeutics Reports 2011 Financial Results, Provides Business Update
Posted: Published on March 15th, 2012
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- InVivo Therapeutics Holdings Corp. (OTCBB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today reported the financial results for the year ended December 31, 2011 and provided a business update. InVivo has pioneered a new treatment that uses a biocompatible polymer-based scaffold to provide structural support to a damaged spinal cord in order to spare tissue from scarring while improving recovering and prognosis after a traumatic spinal cord injury. Today, there is no effective treatment for the spinal cord for paralysis caused by SCIs, and the market potential is estimated to be over $10 billion. 2011 was a landmark year for InVivo, performing under budget for the sixth consecutive year. We made significant progress advancing the commercialization of our first product for SCI and expanding our product pipeline to the rest of the nervous system. We also laid the groundwork to have three product applications under review by FDA by the end of 2012, said Frank Reynolds, InVivos Chief Executive Officer. Our biopolymer scaffolding is poised to enter human clinical trials for SCI during the second half of 2012 and we expect to file two additional Investigational Device Exemptions for our … Continue reading
Posted in Spinal Cord Injury Treatment
Comments Off on InVivo Therapeutics Reports 2011 Financial Results, Provides Business Update
Audiology and Parkinson's Institutes to Present New Medical Research on Parkinson's Associated Fall Prevention at …
Posted: Published on March 15th, 2012
Newport-Mesa Audiology, Balance and Ear Institute and The Parkinsons and Movement Disorders Institute will present medical research on Vestibular Dysfunction in Parkinsons Disease at the American Academy of Audiology research conference (AudiologyNOW!) in Boston, March 28-31, 2012. The new research suggests with proper testing, identification of vestibular abnormalities that affect balance can be treated with vestibular rehabilitation therapy preventing falls, a major source of fatality in Parkinsons disease. Newport Beach, CA (PRWEB) March 15, 2012 According to the research abstract, Significant peripheral and central vestibular dysfunction was found in a group of nine Parkinsons patients of which only a third of the abnormality would be detected with traditional ENG/VNG testing. With proper testing, identification of these abnormalities can be treated with vestibular rehabilitation therapy preventing falls, a major source of fatality in Parkinsons disease. Research presenters and contributors include: According to Dr. Frei, imbalance and falls are commonplace in Parkinsons disease. Loss of postural reflexes is one of the cardinal features of the disorder, however this tends to occur several years following the onset of symptoms. Complaints of imbalance and dizziness are common in Parkinsons patients. The patients are often not clear when asked to describe their symptoms and many … Continue reading
Posted in Parkinson's Treatment
Comments Off on Audiology and Parkinson's Institutes to Present New Medical Research on Parkinson's Associated Fall Prevention at …
Cerebral Palsy In Children – Innovative Intervention Evaluated
Posted: Published on March 15th, 2012
Editor's Choice Main Category: Pediatrics / Children's Health Also Included In: Neurology / Neuroscience Article Date: 15 Mar 2012 - 10:00 PDT email to a friend printer friendly opinions Current Article Ratings: Lauren's mother, Sandy Tierney, said: The pump's delivers a small amount of baclofen - a medication obtained from a mammalian neurotransmitter acid - into the spinal fluid giving Lauren the consistent muscle tone she needs, in order to go about her daily activities more comfortably and quickly, whereas injections and pills wore off or caused fatigue. Lauren explains, as relayed by her mother: "I don't have to take the pill any more, and then I can have breakfast quicker. It helps me get up the stairs more easily, and I'm not so tight." Benedict is currently researching how the baclofen pump and subsequent treatments affect, health, well being, care, functioning and participation in home and community life for individuals suffering with cerebral palsy and their caregivers. Cerebral palsy is one of the most prevalent congenital disorders of childhood. According to Benedict, a lot of resources are being put into supporting children who receive these interventions by health care providers to know that the baclofen pump is effective is … Continue reading
Posted in Cerebral Palsy Treatment
Comments Off on Cerebral Palsy In Children – Innovative Intervention Evaluated